HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lord, S. T. Articles by Colby, T. J. Search for Related Content PubMed PubMed Citation Articles by Lord, S. T. Articles by Colby, T. J. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 265, Issue 2, 838-843, Jan, 1990

Analysis of fibrinogen A alpha-fusion proteins. Mutants which inhibit thrombin equivalently are not equally good substrates

ST Lord, PA Byrd, KL Hede, C Wei and TJ Colby
Department of Pathology, University of North Carolina, Chapel Hill 27599-7525.

We have examined the interaction of thrombin with fibrinogen A alpha chain residues 7-16. Using genetically engineered constructions, we have synthesized in Escherichia coli a fibrinogen A alpha 1-50 fusion protein and seven mutant proteins with single amino acid substitutions. These are: Asp7----Ala, Phe8----Tyr, Glu11----Ala, Gly12----Val, Gly13-- --Val, Gly14----Val, and Arg16----Leu. Competitive immunoassay of cell lysates showed that all the mutations but one, Arg16----Leu, altered the structure of the protein such that cross-reactivity with the A alpha-specific monoclonal antibody, Y18, was significantly reduced. The fusion proteins were purified and analyzed as thrombin inhibitors and substrates. All the fusion proteins are competitive inhibitors of the amidolytic hydrolysis of Spectrozyme TH, a thrombin-specific chromogenic substrate, with inhibition constants corresponding to that for fibrinogen. We conclude that these 7 amino acid substitutions do not alter thrombin binding to the fusion proteins. The fusion proteins were tested as substrates by monitoring thrombin-dependent peptide release. The natural sequence and three mutants, Asp7----Ala, Glu11---- Ala, and Gly14----Val, are good substrates. The other mutants are either poor substrates or are not cleaved by thrombin within A alpha 1- 50. These results indicate that residues between Asp7 and Arg16 are critical to efficient peptide hydrolysis, whereas residues outside this region are critical to thrombin binding.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. T. Lord, M. M. Rooney, K.-P. Hopfner, and E. Di Cera Binding of Fibrinogen Aalpha1-50-beta-Galactosidase Fusion Protein to Thrombin Stabilizes the Slow Form J. Biol. Chem., October 20, 1995; 270(42): 24790 - 24793. [Abstract] [Full Text] [PDF]

				R. Bell, W. K. Stevens, Z. Jia, J. Samis, H. C. F. Cote, R. T. A. MacGillivray, and M. E. Nesheim Fluorescence Properties and Functional Roles of Tryptophan Residues 60d, 96, 148, 207, and 215 of Thrombin J. Biol. Chem., September 15, 2000; 275(38): 29513 - 29520. [Abstract] [Full Text] [PDF]

				J. L. Mullin, O. V. Gorkun, C. G. Binnie, and S. T. Lord Recombinant Fibrinogen Studies Reveal That Thrombin Specificity Dictates Order of Fibrinopeptide Release J. Biol. Chem., August 11, 2000; 275(33): 25239 - 25246. [Abstract] [Full Text] [PDF]